Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets

Generic Name: Dexchlorpheniramine/Methscopolamine/Pseudoephedrine (DEX-klor-fen-IR-a-meen/SOO-doe-e-FED-rin/METH-skoe-POL-a-meen)
Brand Name: DuraHist D

Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets are used for:

Relieving congestion, sneezing, runny nose, and itchy, watery eyes due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.

Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets are an antihistamine, decongestant, and anticholinergic combination. The antihistamine works by blocking histamine, a substance in the body that causes sneezing, runny nose, and watery eyes. The decongestant relieves nasal congestion by shrinking the nasal mucous membranes, which promotes nasal drainage. The anticholinergic dries the chest by decreasing lung secretions.

Do NOT use Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets if:

• you are allergic to any ingredient in Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets


• you take sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days


• you have severe heart blood vessel disease, severe high blood pressure, rapid heartbeat, or severe heart problems


• you have narrow-angle glaucoma, severe bleeding, severe irritation of the esophagus or other serious problems with the esophagus (eg, esophageal achalasia), peptic ulcer, a blockage of your stomach or bowel, bowel motility problems, severe bowel inflammation (eg, ulcerative colitis), certain muscle problems (eg, myasthenia gravis), or uncontrolled bleeding


• you are unable to urinate or are having an asthma attack

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets:

Some medical conditions may interact with Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat or a history of other heart problems


• if you have a history of diabetes, an enlarged prostate or other prostate problems, kidney problems, high blood pressure, asthma, nerve problems, blood clots, a hiatal hernia, an adrenal gland tumor, glaucoma, breathing problems during sleep, seizures, an overactive thyroid, lung problems (eg, emphysema), severe bowel problems, trouble urinating, ulcers, stroke, bladder problems, or a blockage of your stomach, intestines, or bladder

Some MEDICINES MAY INTERACT with Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Alpha-blockers (eg, guanethidine, methyldopa, prazosin), beta-blockers (eg, atenolol), diuretics (eg, furosemide, hydrochlorothiazide), furazolidone, or MAOIs (eg, phenelzine) because the risk of high or low blood pressure may be increased


• Alkalizers (eg, calcium or magnesium antacids), anticholinergics (eg, atropine, benztropine, dicyclomine), carbonic anhydrase inhibitors (eg, acetazolamide), ergotamine, sodium bicarbonate, or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets's side effects


• Bromocriptine, catechol-O-methyltransferase (COMT) inhibitors (eg, entacapone), certain stimulants (eg, doxapram, pseudoephedrine), cocaine, digoxin, droxidopa, potassium chloride, or sodium oxybate (GHB) because the risk of their side effects may be increased by Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets:

Use Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Do not take Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets at the same time as an antacid, certain medicines for diarrhea (eg, attapulgite, bismuth, kaolin, pectin), or ketoconazole. Take these medicines 2 or 3 hours before or after you take Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets.


• Swallow Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets whole. Do not break, crush, or chew before swallowing. Some brands of Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may be broken in half before taking. If you have difficulty swallowing the whole tablet, ask your pharmacist if your brand of medicine may be broken in half.


• If you miss a dose of Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets.

Important safety information:

• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• If your symptoms do not get better within 7 days or if they get worse or you develop a high fever or persistent headache, check with your doctor.


• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may cause dry mouth. To relieve dry mouth, suck on sugarless hard candy or ice chips, chew sugarless gum, drink water, or use a saliva substitute.


• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may make your eyes more sensitive to sunlight. It may help to wear sunglasses.


• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may reduce sweating. Do not become overheated in hot weather or while you are being active; heatstroke may occur.


• Do not take diet or appetite control medicines while you are taking Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets without checking with your doctor.


• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets has dexchlorpheniramine and pseudoephedrine in it. Before you start any new medicine, check the label to see if it has dexchlorpheniramine or pseudoephedrine in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• If you have trouble sleeping, ask your doctor or pharmacist about the best time of the day to take Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets.


• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know that you are taking Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets.


• Tell your doctor or dentist that you take Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets before you receive any medical or dental care, emergency care, or surgery.


• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may interfere with allergy skin tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets for a few days before the tests.


• Diabetes patients - Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Use Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects.


• Caution is advised when using Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets in CHILDREN; they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: It is not known if Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets while you are pregnant. Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets are found in breast milk. Do not breast-feed while taking Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets.

Possible side effects of Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; mental or mood changes; seizures; severe dizziness, lightheadedness, or headache; tremor; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dexchlorpheniramine/Methscopolamine/Pseudoephedrine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include deep sleep or loss of consciousness; hot or cool skin; irregular heartbeat; irritability, anxiety, or panic; large pupils; numbness or tingling in the arms or legs; seizures; slowed or shallow breathing.

Proper storage of Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets:

Store Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.

This information is a summary only. It does not contain all information about Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Sustained-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dexchlorpheniramine/Methscopolamine/Pseudoephedrine resources

• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Side Effects (in more detail)
• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Use in Pregnancy & Breastfeeding
• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Drug Interactions
• Dexchlorpheniramine/Methscopolamine/Pseudoephedrine Support Group
• 0 Reviews for Dexchlorpheniramine/Methscopolamine/Pseudoephedrine - Add your own review/rating

Compare Dexchlorpheniramine/Methscopolamine/Pseudoephedrine with other medications

• Hay Fever
• Rhinitis

Dihydrostreptomycin Werfft

Dihydrostreptomycin Werfft may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dihydrostreptomycin Werfft

Dihydrostreptomycin

Dihydrostreptomycin sulfate (a derivative of Dihydrostreptomycin) is reported as an ingredient of Dihydrostreptomycin Werfft in the following countries:

• Austria

International Drug Name Search

Dextropropoxyphène Paracétamol Qualimed

Dextropropoxyphène Paracétamol Qualimed may be available in the countries listed below.

Ingredient matches for Dextropropoxyphène Paracétamol Qualimed

Dextropropoxyphene

Dextropropoxyphene hydrochloride (a derivative of Dextropropoxyphene) is reported as an ingredient of Dextropropoxyphène Paracétamol Qualimed in the following countries:

• France

Paracetamol

Paracetamol is reported as an ingredient of Dextropropoxyphène Paracétamol Qualimed in the following countries:

• France

International Drug Name Search

Vitamin A Kimia Farma

Vitamin A Kimia Farma may be available in the countries listed below.

Ingredient matches for Vitamin A Kimia Farma

Retinol

Retinol acetate (a derivative of Retinol) is reported as an ingredient of Vitamin A Kimia Farma in the following countries:

• Indonesia

International Drug Name Search

Psycoton

Psycoton may be available in the countries listed below.

Ingredient matches for Psycoton

Piracetam

Piracetam is reported as an ingredient of Psycoton in the following countries:

• Italy

International Drug Name Search

Zelnorm

In the US, Zelnorm (tegaserod systemic) is a member of the drug class serotoninergic neuroenteric modulators and is used to treat Constipation - Chronic and Irritable Bowel Syndrome.

US matches:

• Zelnorm

Ingredient matches for Zelnorm

Tegaserod

Tegaserod maleate (a derivative of Tegaserod) is reported as an ingredient of Zelnorm in the following countries:

• Philippines

International Drug Name Search

Konveril Plus

Konveril Plus may be available in the countries listed below.

Ingredient matches for Konveril Plus

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Konveril Plus in the following countries:

• Bulgaria

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Konveril Plus in the following countries:

• Bulgaria

International Drug Name Search

Kinidin "Dak"

Kinidin "Dak" may be available in the countries listed below.

Ingredient matches for Kinidin "Dak"

Quinidine

Quinidine sulfate (a derivative of Quinidine) is reported as an ingredient of Kinidin "Dak" in the following countries:

• Denmark

International Drug Name Search

Lexinor

Lexinor may be available in the countries listed below.

Ingredient matches for Lexinor

Norfloxacin

Norfloxacin is reported as an ingredient of Lexinor in the following countries:

• Philippines


• Thailand

International Drug Name Search

Anginox

Anginox may be available in the countries listed below.

Ingredient matches for Anginox

Trimetazidine

Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Anginox in the following countries:

• Bangladesh

International Drug Name Search

Holetar

Holetar may be available in the countries listed below.

Ingredient matches for Holetar

Lovastatin

Lovastatin is reported as an ingredient of Holetar in the following countries:

• Bulgaria


• Czech Republic


• Latvia


• Lithuania


• Romania


• Russian Federation


• Slovenia

International Drug Name Search

Ondansetron Gobbi

Ondansetron Gobbi may be available in the countries listed below.

Ingredient matches for Ondansetron Gobbi

Ondansetron

Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Ondansetron Gobbi in the following countries:

• Argentina

International Drug Name Search

LH RH

LH-RH may be available in the countries listed below.

Ingredient matches for LH-RH

Gonadorelin

Gonadorelin acetate (a derivative of Gonadorelin) is reported as an ingredient of LH-RH in the following countries:

• Japan


• Turkey

International Drug Name Search

Pyridoxine HCl CF

Pyridoxine HCl CF may be available in the countries listed below.

Ingredient matches for Pyridoxine HCl CF

Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Pyridoxine HCl CF in the following countries:

• Netherlands

International Drug Name Search

Gentamen

Gentamen may be available in the countries listed below.

Ingredient matches for Gentamen

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamen in the following countries:

• Italy

International Drug Name Search

Metrol

Metrol may be available in the countries listed below.

Ingredient matches for Metrol

Methylergometrine

Methylergometrine is reported as an ingredient of Metrol in the following countries:

• Tunisia

Metronidazole

Metronidazole benzoate (a derivative of Metronidazole) is reported as an ingredient of Metrol in the following countries:

• Ethiopia

International Drug Name Search

Orapred Solution

Pronunciation: pred-NIS-oh-lone SO-dee-uhm FOSS-fate
Generic Name: Prednisolone Sodium Phosphate
Brand Name: Orapred

Orapred Solution is used for:

Treating severe allergies, arthritis, asthma, certain blood disorders, and skin conditions. It may also be used for other conditions as determined by your doctor.

Orapred Solution is a corticosteroid. It works by modifying the body's immune response to various conditions and decreasing inflammation.

Do NOT use Orapred Solution if:

• you are allergic to any ingredient in Orapred Solution


• you have a systemic fungal infection, a certain type of malaria, inflammation of the optic nerve, or herpes infection of the eye


• you are scheduled to have a live or attenuated live vaccination (eg, smallpox)


• you are taking mifepristone

Contact your doctor or health care provider right away if any of these apply to you.

Before using Orapred Solution:

Some medical conditions may interact with Orapred Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of heart problems (eg, congestive heart failure), heart attack, high blood pressure, kidney problems, liver problems, diabetes, seizures, an underactive thyroid, adrenal gland problems, or any mental or mood problems


• if you have or have recently had a fungal, bacterial, viral, or other type of infection; herpes infection of the eye; chickenpox; measles; or shingles


• if you have HIV infection or tuberculosis (TB) infection, or if you have had ever had a positive TB skin test


• if you have any stomach problems (eg, ulcers), intestinal problems (eg, blockage, perforation, or infection; unexplained diarrhea; diverticulitis; ulcerative colitis), recent intestinal surgery, or inflammation of the esophagus


• if you have weak bones (eg, osteoporosis) or muscle problems (eg, myasthenia gravis)


• if you have had a recent vaccination (eg, smallpox)

Some MEDICINES MAY INTERACT with Orapred Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Barbiturates (eg, phenobarbital), carbamazepine, ephedrine, hydantoins (eg, phenytoin), or rifampin because they may decrease Orapred Solution's effectiveness


• Clarithromycin, cyclosporine, estrogens (eg, estradiol), oral contraceptives (eg, birth control pills), or ketoconazole because they may increase the risk of Orapred Solution's side effects


• Anticholinesterases (eg, pyridostigmine), aspirin, diuretics, furosemide, hydrochlorothiazide, live or attenuated live vaccines (eg, smallpox), methotrexate, mifepristone, or ritodrine because the risk of their side effects may be increased by Orapred Solution


• Anticoagulants (eg, warfarin) or killed or inactivated vaccines because their effectiveness may be decreased by Orapred Solution

This may not be a complete list of all interactions that may occur. Ask your health care provider if Orapred Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Orapred Solution:

Use Orapred Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Orapred Solution by mouth with food.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Orapred Solution and you are taking 1 dose daily, take it as soon as possible. If you do not remember until the next day, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Orapred Solution.

Important safety information:

• Orapred Solution may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.


• If you have not had chickenpox, shingles, or measles, avoid contact with anyone who does.


• Report to your doctor any injuries or signs of infection (fever, sore throat, pain during urination, or muscle aches) for up to 12 months after stopping Orapred Solution.


• Carry an ID card at all times that says you take Orapred Solution.


• Do not receive a live vaccine (eg, measles, mumps) while you are taking Orapred Solution. Talk with your doctor before you receive any vaccine.


• Tell your doctor or dentist that you take Orapred Solution before you receive any medical or dental care, emergency care, or surgery.


• Diabetes patients - Orapred Solution may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Lab tests, including adrenal function tests, may be performed while you use Orapred Solution. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Caution is advised when using Orapred Solution in CHILDREN; they may be more sensitive to its effects.


• Corticosteroids may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they take Orapred Solution.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Orapred Solution while you are pregnant. Orapred Solution is found in breast milk. If you are or will be breast-feeding while you use Orapred Solution, check with your doctor. Discuss any possible risks to your baby.

If you are on long-term or high dosage therapy and you suddenly stop taking Orapred Solution, you may have WITHDRAWAL symptoms, including fever, vomiting, appetite loss, diarrhea, nausea, dizziness, weight loss, weakness, general body discomfort, or joint or muscle pain.

Possible side effects of Orapred Solution:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Acne; clumsiness; dizziness; facial flushing; feeling of a whirling motion; general body discomfort; headache; increased appetite; increased sweating; nausea; nervousness; sleeplessness; upset stomach.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; changes in body fat; changes in menstrual period; changes in skin color; chest pain; easy bruising or bleeding; infection (eg, fever, chills, sore throat); mental or mood changes (eg, depression); muscle pain, weakness, or wasting; seizures; severe nausea or vomiting; sudden severe dizziness or headache; swelling of feet or legs; tendon or bone pain; thinning of skin; unusual skin sensation; unusual weight gain; vision changes or other eye problems; vomit that looks like coffee grounds.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Orapred side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Orapred Solution:

Check with your pharmacist for storage instructions. Some brands of Orapred Solution (eg, Orapred) must be stored in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Others may be stored at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Do not freeze. Keep Orapred Solution out of the reach of children and away from pets.

General information:

• If you have any questions about Orapred Solution, please talk with your doctor, pharmacist, or other health care provider.


• Orapred Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Orapred Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Orapred resources

• Orapred Side Effects (in more detail)
• Orapred Use in Pregnancy & Breastfeeding
• Orapred Drug Interactions
• Orapred Support Group
• 2 Reviews for Orapred - Add your own review/rating

Compare Orapred with other medications

• Asthma, acute
• Bronchopulmonary Dysplasia
• Bullous Pemphigoid
• Dermatitis
• Immunosuppression
• Inflammatory Conditions
• Multiple Sclerosis
• Nephrotic Syndrome
• Pemphigoid
• Pemphigus

Ocufen Drops

Pronunciation: flure-BI-proe-fen
Generic Name: Flurbiprofen
Brand Name: Ocufen

Ocufen Drops are used for:

Preventing a decrease in pupil size during surgery. It may also be used for other conditions as determined by your doctor.

Ocufen Drops are a nonsteroidal anti-inflammatory drug (NSAID) eye drop. It works by blocking a certain substance that causes inflammation (redness, swelling, and irritation).

Do NOT use Ocufen Drops if:

• you are allergic to any ingredient in Ocufen Drops


• you are in late pregnancy

Contact your doctor or health care provider right away if any of these apply to you.

Before using Ocufen Drops:

Some medical conditions may interact with Ocufen Drops. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to aspirin or any medicine containing aspirin or an NSAID (eg, ibuprofen)


• if you have bleeding problems


• if you have other eye problems (eg, dry eye syndrome, cornea problems), have had complicated eye surgery, or have had repeated eye surgeries within a short period of time

Some MEDICINES MAY INTERACT with Ocufen Drops. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin) or heparin because the risk of bleeding may be increased


• Acetylcholine or carbachol because their effectiveness may be decreased by Ocufen Drops

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ocufen Drops may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Ocufen Drops:

Use Ocufen Drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• To use Ocufen Drops, wash your hands. Tilt your head back. Using your index finger, pull the lower eyelid away from the eye to form a pouch. Drop the medicine into the pouch and gently close your eyes. Immediately use your finger to apply pressure to the inside corner of the eye for 1 to 2 minutes. Do not blink. Remove excess medicine around your eye with a clean tissue, being careful not to touch your eye. Wash your hands to remove any medicine that may be on them. To prevent germs from contaminating your medicine, do not touch the applicator tip to any surface, including your eye. Keep the container tightly closed.


• Do not administer Ocufen Drops while wearing contact lenses. Talk to your doctor about the proper use of Ocufen Drops if you usually wear contact lenses.


• If you miss a dose of Ocufen Drops, contact your doctor immediately.

Ask your health care provider any questions you may have about how to use Ocufen Drops.

Important safety information:

• Do not exceed the recommended dose or take Ocufen Drops for longer than prescribed without checking with your doctor.


• Use Ocufen Drops with caution in CHILDREN younger than 18 years of age. Safety and efficacy in this age group have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Ocufen Drops during pregnancy. Avoid use of Ocufen Drops during late pregnancy. It is unknown if Ocufen Drops are excreted in breast milk. Do not breast-feed while using Ocufen Drops.

Possible side effects of Ocufen Drops:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Sensitivity of the eyes to light; temporary burning, irritation, itching, pain, redness, stinging, or swelling of the eye.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bleeding of the eye; sensitivity to light; severe burning, irritation, itching, redness, stinging, or swelling of the eye; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Ocufen side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Ocufen Drops:

Store Ocufen Drops between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ocufen Drops out of the reach of children and away from pets.

General information:

• If you have any questions about Ocufen Drops, please talk with your doctor, pharmacist, or other health care provider.


• Ocufen Drops are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ocufen Drops. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ocufen resources

• Ocufen Side Effects (in more detail)
• Ocufen Dosage
• Ocufen Use in Pregnancy & Breastfeeding
• Ocufen Drug Interactions
• Ocufen Support Group
• 0 Reviews for Ocufen - Add your own review/rating

Compare Ocufen with other medications

• Inhibition of Intraoperative Miosis
• Postoperative Ocular Inflammation

Ultracain

Ultracain may be available in the countries listed below.

Ingredient matches for Ultracain

Articaine

Articaine hydrochloride (a derivative of Articaine) is reported as an ingredient of Ultracain in the following countries:

• Austria


• Georgia


• Germany


• Turkey

Epinephrine

Epinephrine hydrochloride (a derivative of Epinephrine) is reported as an ingredient of Ultracain in the following countries:

• Austria

International Drug Name Search

Salsoroitin N

Salsoroitin N may be available in the countries listed below.

Ingredient matches for Salsoroitin N

Chondroitin Polysulfate

Chondroitin Polysulfate sodium salt (a derivative of Chondroitin Polysulfate) is reported as an ingredient of Salsoroitin N in the following countries:

• Japan

Salicylic Acid

Salicylic Acid sodium (a derivative of Salicylic Acid) is reported as an ingredient of Salsoroitin N in the following countries:

• Japan

International Drug Name Search

Exosurf

In the US, Exosurf is a member of the drug class lung surfactants.

Ingredient matches for Exosurf

Colfosceril

Colfosceril Palmitate is reported as an ingredient of Exosurf in the following countries:

• Bahrain


• Iran


• Kuwait


• Luxembourg


• Qatar


• United Arab Emirates

International Drug Name Search

Aroxat

Aroxat may be available in the countries listed below.

Ingredient matches for Aroxat

Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Aroxat in the following countries:

• Chile

International Drug Name Search

Sulfamérazine

Sulfamérazine may be available in the countries listed below.

Ingredient matches for Sulfamérazine

Sulfamerazine

Sulfamérazine (DCF) is also known as Sulfamerazine (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dobutamine Aguettant

Dobutamine Aguettant may be available in the countries listed below.

Ingredient matches for Dobutamine Aguettant

Dobutamine

Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Dobutamine Aguettant in the following countries:

• France

International Drug Name Search

Sanitropina G

Sanitropina G may be available in the countries listed below.

Ingredient matches for Sanitropina G

Simeticone

Simeticone is reported as an ingredient of Sanitropina G in the following countries:

• Peru

International Drug Name Search

Droxifan

Droxifan may be available in the countries listed below.

Ingredient matches for Droxifan

Cefadroxil

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Droxifan in the following countries:

• Venezuela

International Drug Name Search

Ovidon

Ovidon may be available in the countries listed below.

Ingredient matches for Ovidon

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Ovidon in the following countries:

• Hungary

Levonorgestrel

Levonorgestrel is reported as an ingredient of Ovidon in the following countries:

• Hungary

International Drug Name Search

Physiomycine

Physiomycine may be available in the countries listed below.

Ingredient matches for Physiomycine

Metacycline

Metacycline is reported as an ingredient of Physiomycine in the following countries:

• Tunisia

Metacycline hydrochloride (a derivative of Metacycline) is reported as an ingredient of Physiomycine in the following countries:

• France

International Drug Name Search

Fexo

Fexo may be available in the countries listed below.

Ingredient matches for Fexo

Fexofenadine

Fexofenadine hydrochloride (a derivative of Fexofenadine) is reported as an ingredient of Fexo in the following countries:

• South Africa

International Drug Name Search

Losartan Steiner

Losartan Steiner may be available in the countries listed below.

Ingredient matches for Losartan Steiner

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Steiner in the following countries:

• Germany

International Drug Name Search

Medivet Trio S

Medivet Trio S may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Medivet Trio S

Sulfadimidine

Sulfadimidine is reported as an ingredient of Medivet Trio S in the following countries:

• Switzerland

Sulfathiazole

Sulfathiazole is reported as an ingredient of Medivet Trio S in the following countries:

• Switzerland

Trimethoprim

Trimethoprim is reported as an ingredient of Medivet Trio S in the following countries:

• Switzerland

International Drug Name Search

Biafine Emulsion

Pronunciation: i-MUL-shun
Generic Name: Wound Dressing
Brand Name: Biafine

Biafine Emulsion is used for:

Treating minor cuts, burns (including sunburns), and wounds; pressure sores; skin ulcers; skin graft or donor sites; or skin inflammation caused by radiation treatment. It may also be used for other skin conditions as determined by your doctor.

Biafine Emulsion is a wound dressing. It works by providing moisture for the healing process and protecting the healing wound from contamination.

Do NOT use Biafine Emulsion if:

• you are allergic to any ingredient in Biafine Emulsion


• you have a bleeding wound


• you have a skin rash caused by an allergic reaction to food or medicine

Contact your doctor or health care provider right away if any of these apply to you.

Before using Biafine Emulsion:

Some medical conditions may interact with Biafine Emulsion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you are or will be receiving radiation therapy


• if you have signs of an infection (eg, redness, swelling) at the application site

Some MEDICINES MAY INTERACT with Biafine Emulsion. Because little, if any, of Biafine Emulsion is absorbed into the blood, the risk of it interacting with another medicine is low.

Ask your health care provider if Biafine Emulsion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Biafine Emulsion:

Use Biafine Emulsion as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Wash your hands before using Biafine Emulsion.


• If you are using Biafine Emulsion on a wound or a skin graft or donor site, wash the affected area with saline, water, or wound cleanser. Apply a 1 4 - to ½-inch-thick layer of medicine to the affected area. If you will be using gauze dressing, moisten the dressing lightly before applying it on the wound.


• If you are using Biafine Emulsion on a skin graft, apply it only after the graft has successfully taken. If you need to wash Biafine Emulsion off, you may use a saline solution or clean water.


• If you are using Biafine Emulsion for minor burns, including sunburns, be sure to remove any clothing from the affected area before you apply it. Apply a 1 4 - to ½-inch-thick layer to the affected area. Gently rub in until the skin no longer absorbs the medicine. A white waxy residue may remain. If pain persists, apply thin layers of Biafine Emulsion until the pain goes away. Contact your doctor if the pain does not stop or if it worsens.


• If you are using Biafine Emulsion for skin inflammation caused by radiation treatment, gently massage it into the affected area until it is completely absorbed. Do not stop using Biafine Emulsion during treatment, even for one day, unless your doctor tells you otherwise. Do not apply Biafine Emulsion within 4 hours before radiation treatment.


• Wash your hands after using Biafine Emulsion, unless your hands are a part of the treated area.


• Continue to use Biafine Emulsion as directed by your doctor until your skin has fully healed. Do not miss any doses.


• If you miss a dose of Biafine Emulsion, use it as soon as you remember. Continue to use it as directed by your doctor.

Ask your health care provider any questions you may have about how to use Biafine Emulsion.

Important safety information:

• Biafine Emulsion is for external use only. Do not get it in your eyes, nose, or mouth. If you get it in your eyes, rinse right away with cool tap water.


• Talk with your doctor before you use any other medicines or cleansers on your skin.


• Biafine Emulsion does not contain sunscreen. Ask your doctor before use if you must be outside for more than a short time.


• If your symptoms do not get better within 10 to 14 days or if they get worse, check with your doctor.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Biafine Emulsion while you are pregnant. If you are or will be breast-feeding while you use Biafine Emulsion, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Biafine Emulsion:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Tingling.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Biafine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Biafine Emulsion:

Store Biafine Emulsion at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Do not freeze. Keep Biafine Emulsion out of the reach of children and away from pets.

General information:

• If you have any questions about Biafine Emulsion, please talk with your doctor, pharmacist, or other health care provider.


• Biafine Emulsion is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Biafine Emulsion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Biafine resources

• Biafine Side Effects (in more detail)
• Biafine Use in Pregnancy & Breastfeeding
• Biafine Support Group
• 2 Reviews for Biafine - Add your own review/rating

Compare Biafine with other medications

• Dry Skin

Laproton

Laproton may be available in the countries listed below.

Ingredient matches for Laproton

Lansoprazole

Lansoprazole is reported as an ingredient of Laproton in the following countries:

• Indonesia

International Drug Name Search

Raspjine

Raspjine may be available in the countries listed below.

Ingredient matches for Raspjine

Azelastine

Azelastine hydrochloride (a derivative of Azelastine) is reported as an ingredient of Raspjine in the following countries:

• Japan

International Drug Name Search

Tromic

Tromic may be available in the countries listed below.

Ingredient matches for Tromic

Azithromycin

Azithromycin is reported as an ingredient of Tromic in the following countries:

• Dominican Republic

International Drug Name Search

Enalapril Cinfa

Enalapril Cinfa may be available in the countries listed below.

Ingredient matches for Enalapril Cinfa

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Cinfa in the following countries:

• Portugal


• Spain

International Drug Name Search

Acatar Zatoki

Acatar Zatoki may be available in the countries listed below.

Ingredient matches for Acatar Zatoki

Ibuprofen

Ibuprofen is reported as an ingredient of Acatar Zatoki in the following countries:

• Poland

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Acatar Zatoki in the following countries:

• Poland

International Drug Name Search

Dicyclomine

In the US, Dicyclomine (dicyclomine systemic) is a member of the drug class anticholinergics/antispasmodics and is used to treat Irritable Bowel Syndrome.

US matches:

• Dicyclomine


• Dicyclomine Capsules


• Dicyclomine Syrup


• Dicyclomine Hydrochloride


• Dicyclomine Injection


• Dicyclomine Tablets

Ingredient matches for Dicyclomine

Dicycloverine

Dicyclomine (BAN) is also known as Dicycloverine (Rec.INN)

International Drug Name Search

Glossary

BAN	British Approved Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Carboplatino

Carboplatino may be available in the countries listed below.

Ingredient matches for Carboplatino

Carboplatin

Carboplatino (DCIT) is known as Carboplatin in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Amantadin-HCl Sandoz

Amantadin-HCl Sandoz may be available in the countries listed below.

Ingredient matches for Amantadin-HCl Sandoz

Amantadine

Amantadine hydrochloride (a derivative of Amantadine) is reported as an ingredient of Amantadin-HCl Sandoz in the following countries:

• Germany

International Drug Name Search

Unakalm

Unakalm may be available in the countries listed below.

Ingredient matches for Unakalm

Ketazolam

Ketazolam is reported as an ingredient of Unakalm in the following countries:

• Portugal

International Drug Name Search

Optiray 320

Generic Name: ioversol (eye oh VERS ol)

Brand Names: Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350

What is Optiray 320 (ioversol)?

Ioversol is in a group of drugs called radiopaque (RAY dee oh payk) contrast agents. Ioversol contains iodine, a substance that absorbs x-rays. Radiopaque contrast agents are used to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (x-ray) examination.

Ioversol is used to help diagnose certain disorders of the heart, brain, and blood vessels.

Ioversol may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about Optiray 320 (ioversol)?

You should not receive ioversol if you have any type of active infection.

Tell your doctor if you have asthma, hay fever, or history of food or drug allergies, especially if you have had any type of reaction to another contrast agent.

Drink extra fluids before and after you receive ioversol. This medication can cause you to get dehydrated, which can lead to dangerous effects on your kidneys. Follow your doctor's instructions about the types and amount of fluids you should drink before and after your test.

What should I discuss with my health care provider before receiving Optiray 320 (ioversol)?

Tell your doctor if you have ever had any type of reaction to another contrast agent.

You should not receive ioversol if you have any type of active infection.

Before receiving ioversol, tell your doctor if you have:

• 
  

  a brain tumor or hematoma;

  
  


• 
  

  a recent head or brain injury;

  
  


• 
  

  epilepsy or other seizure disorder;

  
  


• 
  

  a bleeding or blood clotting disorder;

  
  


• 
  

  kidney disease;

  
  


• 
  

  liver disease;

  
  


• 
  

  diabetes;

  
  


• 
  

  heart disease, angina, or congestive heart failure;

  
  


• 
  

  homocysteinuria;

  
  


• 
  

  sickle cell disease;

  
  


• 
  

  a history of stroke, blood clots, or circulation problems;

  
  


• 
  

  asthma, hay fever, or a history of food or drug allergies;

  
  


• 
  

  multiple myeloma (bone cancer);

  
  


• 
  

  pheochromocytoma; or

  
  


• 
  

  a thyroid disorder.

  
  

If you have any of these conditions, you may not be able to receive ioversol, or you may need a dosage adjustment or special tests during treatment.

FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether ioversol passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Older adults may need special care in avoiding dehydration by drinking extra fluids before and after the radiologic test. Your kidney function may also need to be watched closely after you have received ioversol.

How is ioversol used?

Ioversol is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting during your radiologic test.

Drink extra fluids before and after you receive ioversol. This medication can cause you to get dehydrated, which can lead to dangerous effects on your kidneys. Follow your doctor's instructions about the types and amount of fluids you should drink before and after your test. Your doctor or other healthcare provider may want to watch you for a short period of time after your injection. This is to make sure you do not have any unwanted side effects or delayed reactions.

This medication can cause you to have unusual results with certain thyroid tests. If you have such tests within 16 days after receiving ioversol, tell the doctor in charge that you have recently received ioversol.

What happens if I miss a dose?

Since ioversol is used only during your radiologic test, you will not be on a dosing schedule.

What happens if I overdose?

Seek emergency medical attention if you think you have received too much of this medicine. Symptoms of an ioversol overdose may include chest pain, trouble breathing, and slow or uneven heartbeats.

What should I avoid while receiving Optiray 320 (ioversol)?

Do not allow yourself to become dehydrated during the first few days after receiving ioversol. Call your doctor if you have any vomiting or diarrhea during this time. Follow your doctor's instructions about the types and amount of fluids you should drink.

Optiray 320 (ioversol) side effects

Some of the side effects of ioversol can occur up to 24 hours after you have received the medication.

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

• 
  

  urinating less than usual or not at all;

  
  


• 
  

  severe muscle pain or weakness;

  
  


• 
  

  seizure (convulsions);

  
  


• 
  

  chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;

  
  


• 
  

  sudden numbness or weakness, especially on one side of the body;

  
  


• 
  

  sudden headache, confusion, problems with vision, speech, or balance;

  
  


• 
  

  feeling light-headed, fainting;

  
  


• 
  

  wheezing, trouble breathing;

  
  


• 
  

  fast or slow heartbeat;

  
  


• 
  

  easy bruising, unusual bleeding, or skin changes; or

  
  


• 
  

  swelling of your hands, ankles, or feet.

  
  

Other less serious side effects are more likely to occur, such as:

• 
  

  fever, warmth, or pain;

  
  


• 
  

  skin rash or redness;

  
  


• 
  

  headache; or

  
  


• 
  

  nausea.

  
  

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Optiray 320 (ioversol)?

There may be other drugs that can affect ioversol. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

More Optiray 320 resources

• Optiray 320 Side Effects (in more detail)
• Optiray 320 Use in Pregnancy & Breastfeeding
• Optiray 320 Drug Interactions
• Optiray 320 Support Group
• 0 Reviews for Optiray 320 - Add your own review/rating

Compare Optiray 320 with other medications

• Body Imaging
• Cerebral Arteriography
• Coronary Arteriography
• Head Imaging
• Intra-arterial Digital Subtraction Angiography
• Intravenous Digital Subtraction Angiography
• Intravenous Urography
• Left Ventriculography
• Pediatric Angiocardiography
• Peripheral Arteriography
• Renal Arteriography
• Venography
• Visceral Arteriography

Where can I get more information?

• Your doctor or pharmacist has more information about ioversol written for health professionals that you may read.

See also: Optiray 320 side effects (in more detail)

Fibrimol

Fibrimol may be available in the countries listed below.

Ingredient matches for Fibrimol

Paracetamol

Paracetamol is reported as an ingredient of Fibrimol in the following countries:

• Chile

International Drug Name Search

Pepfamin

Pepfamin may be available in the countries listed below.

Ingredient matches for Pepfamin

Famotidine

Famotidine is reported as an ingredient of Pepfamin in the following countries:

• Thailand

International Drug Name Search

Remena

Remena may be available in the countries listed below.

Ingredient matches for Remena

Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Remena in the following countries:

• Greece

International Drug Name Search

Rimivat

Rimivat may be available in the countries listed below.

Ingredient matches for Rimivat

Oseltamivir

Oseltamivir phosphate (a derivative of Oseltamivir) is reported as an ingredient of Rimivat in the following countries:

• Chile

International Drug Name Search

Normafem

Normafem may be available in the countries listed below.

Ingredient matches for Normafem

Nystatin

Nystatin is reported as an ingredient of Normafem in the following countries:

• Colombia

International Drug Name Search

Recort Plus cream, ointment, suppository

Generic Name: hydrocortisone rectal (cream, ointment, suppository) (hye dro KORT i zone REK tal)

Brand Names: Anucort-HC, Anumed-HC, Anusol-HC, Cortizone-10 Anal Itch Cream, Hemorrhoidal HC, Hemril-30, Hemril-HC Uniserts, Preparation H Hydrocortisone, Procto-Kit 1%, Procto-Kit 2.5%, Procto-Pak 1%, Proctocort, Proctocream-HC, Proctosert HC, Proctosol-HC, Proctozone HC, Proctozone-H, Recort Plus, Rectasol-HC, Tucks HC

What is hydrocortisone rectal?

Hydrocortisone is a steroid medicine that reduces inflammation in the body.

The information in this medication guide is specific to hydrocortisone rectal cream, ointment, or suppository.

Hydrocortisone rectal is used to treat itching or swelling caused by hemorrhoids or other inflammatory conditions of the rectum or anus.

Hydrocortisone rectal is also used together with other medications to treat ulcerative colitis, proctitis, and other inflammatory conditions of the lower intestines and rectal area.

Hydrocortisone rectal may also be used for purposes not listed in this medication guide.

What is the most important information I should know about hydrocortisone rectal?

The information in this medication guide is specific to hydrocortisone rectal cream, ointment, or suppository.

Do not take hydrocortisone rectal by mouth. It is for use only in your rectum.

This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions. You may need to use this medication for up to 8 weeks.

Call your doctor at once if you have any bleeding from your rectum, feeling short of breath (even with mild exertion), swelling of your ankles or feet, or rapid weight gain.

There may be other drugs that can interact with hydrocortisone rectal. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

Call your doctor if your symptoms do not improve or if they get worse after using this medicine for a few days.

What should I discuss with my health care provider before using hydrocortisone rectal?

Ask a doctor or pharmacist if it is safe for you to use this medicine if you have:

• 
  

  congestive heart failure;

  
  


• 
  

  a history of tuberculosis;

  
  


• 
  

  stomach ulcer or diverticulitis;

  
  


• 
  

  a colostomy or ileostomy;

  
  


• 
  

  fever or any type of infection;

  
  


• 
  

  kidney disease;

  
  


• 
  

  high blood pressure; or

  
  


• 
  

  myasthenia gravis.

  
  

Also tell your doctor if you have diabetes. Steroid medicines may increase the glucose (sugar) levels in your blood or urine. You may also need to adjust the dose of your diabetes medications.

FDA pregnancy category C. It is not known whether hydrocortisone rectal will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether hydrocortisone passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use hydrocortisone rectal?

Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.

Do not take hydrocortisone rectal by mouth. It is for use only in your rectum.

This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions. You may need to use this medication for up to 8 weeks.

Wash your hands before and after using this medicine.

Try to empty your bowel and bladder just before using hydrocortisone rectal.

Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands. The rectal suppository can stain clothing or other fabrics it comes into contact with.

For best results from the suppository, lie down after inserting it and hold in the suppository. The suppository will melt quickly once inserted and you should feel little or no discomfort while holding it in.

For best results from the cream, use only the applicator provided with the medication. Otherwise, follow the directions provided with your rectal cream.

Avoid using the bathroom for one to three hours after inserting the cream or suppository.

Apply the ointment to the rectum and surrounding skin of the rectal area as directed on the package label.

Call your doctor if your symptoms do not improve or if they get worse after using this medicine for a few days.

Store the rectal cream at room temperature away from moisture and heat. Store the rectal suppositories at cool room temperature away from moisture and heat. Do not refrigerate or freeze them.

What happens if I miss a dose?

Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

An overdose of hydrocortisone rectal is not expected to produce life-threatening symptoms. However, long-term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.

What should I avoid while using hydrocortisone rectal ?

Avoid getting a vaccine during your treatment with hydrocortisone rectal. Vaccines may not work as well while you are using a steroid medicine.

Hydrocortisone rectal side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:

• 
  

  feeling short of breath, even with mild exertion;

  
  


• 
  

  swelling of your ankles or feet;

  
  


• 
  

  muscle weakness;

  
  


• 
  

  rapid weight gain, especially in your face and midsection;

  
  


• 
  

  severe rectal pain or burning;

  
  


• 
  

  bleeding from your rectum;

  
  


• 
  

  severe stomach pain;

  
  


• 
  

  sudden and severe headache or pain behind your eyes; or

  
  


• 
  

  seizure (convulsions).

  
  

Less serious side effects may include:

• 
  

  mild rectal pain or burning;

  
  


• 
  

  acne;

  
  


• 
  

  changes in your menstrual periods;

  
  


• 
  

  increased sweating; or

  
  


• 
  

  increased facial or body hair growth.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect hydrocortisone rectal ?

Before using hydrocortisone rectal, tell your doctor if you also use insulin or take oral diabetes medication.

There may be other drugs that can interact with hydrocortisone rectal. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More Recort Plus resources

• Recort Plus Side Effects (in more detail)
• Recort Plus Use in Pregnancy & Breastfeeding
• Recort Plus Drug Interactions
• Recort Plus Support Group
• 0 Reviews for Recort Plus - Add your own review/rating

Compare Recort Plus with other medications

• Anal Itching
• Aphthous Stomatitis, Recurrent
• Atopic Dermatitis
• Dermatitis
• Eczema
• Gingivitis
• Proctitis
• Pruritus
• Psoriasis
• Seborrheic Dermatitis
• Ulcerative Colitis, Active

Where can I get more information?

• Your pharmacist can provide more information about hydrocortisone rectal cream, ointment, or suppository.

See also: Recort Plus side effects (in more detail)

Bilosin

Bilosin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bilosin

Tylosin

Tylosin is reported as an ingredient of Bilosin in the following countries:

• Ireland


• United Kingdom

International Drug Name Search

Tramadol Lannacher

Tramadol Lannacher may be available in the countries listed below.

Ingredient matches for Tramadol Lannacher

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol Lannacher in the following countries:

• Bulgaria


• Czech Republic


• Estonia


• Latvia


• Lithuania


• Luxembourg


• Russian Federation

International Drug Name Search

Stérilène

Stérilène may be available in the countries listed below.

Ingredient matches for Stérilène

Cetrimide

Cetrimide is reported as an ingredient of Stérilène in the following countries:

• France

International Drug Name Search

Androstanolone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A14AA01,G03BB02

CAS registry number (Chemical Abstracts Service)

0000521-18-6

Chemical Formula

C19-H30-O2

Molecular Weight

290

Therapeutic Categories

Anabolic

Androgen

Chemical Name

Androstan-3-one, 17-hydroxy-, (5α,17ß)-

Foreign Names

• Androstanolonum (Latin)
• Androstanolon (German)
• Androstanolone (French)
• Androstanolona (Spanish)

Generic Names

• Androstanolone (OS: BAN, DCF, DCIT)
• Dihydrotestosterone (IS)
• Stanolone (IS)
• Stanolone (PH: BP 1980)

Brand Names

• Andractim
  Besins, Belgium; Besins, France; Besins, Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Panacef

Panacef may be available in the countries listed below.

Ingredient matches for Panacef

Cefaclor

Cefaclor monohydrate (a derivative of Cefaclor) is reported as an ingredient of Panacef in the following countries:

• Italy

International Drug Name Search